Manufacturing process for crystal with reduced coenzyme Q10 with excellent stability
DE602019078112T2Active Publication Date: 2025-11-12KANEKA CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DE602019078112
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2019-08-29
- Publication Date
- 2025-11-12
- Estimated Expiration
- 2039-08-29
AI Technical Summary
Technical Problem
Existing methods for producing reduced coenzyme Q10 Form II crystal are inefficient and lack industrial scalability, often requiring long times and low yields, and may not produce the crystal under certain conditions.
Method used
A method involving the use of reduced coenzyme Q10 Form II crystal as a seed crystal in a specific solvent, within a defined temperature range, and controlled cooling and stirring conditions to achieve high yield and stability.
Benefits of technology
The method enables the efficient production of a stable reduced coenzyme Q10 Form II crystal suitable for industrial scale, with improved reproducibility and purity.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.